e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Resistant and MDR tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary drug resistant
Mycobacterium tuberculosis
in a tertiary TB center in Iran
S. M. Mirsaeidi, P. Tabarsi, P. Farnia, M. Amiri, S. D. Mansouri, M. R. Masjedi, A. A. Velayati (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2005 - Resistant and MDR tuberculosis
Session:
Resistant and MDR tuberculosis
Session type:
Thematic Poster Session
Number:
4124
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. M. Mirsaeidi, P. Tabarsi, P. Farnia, M. Amiri, S. D. Mansouri, M. R. Masjedi, A. A. Velayati (Tehran, Islamic Republic Of Iran). Primary drug resistant
Mycobacterium tuberculosis
in a tertiary TB center in Iran. Eur Respir J 2005; 26: Suppl. 49, 4124
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Prevalence of fluoroquinolone resistance in
mycobacterium tuberculosis
in a tertiary care hospital in India
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
The prevalence of non-tuberculous mycobacterium pulmonary infection in a tertiary hospital in Singapore
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Primary drug resistance against mycobacterium tuberculosis in a high burden country
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Pattern of drug resistance and treatment outcome of pulmonary tuberculosis treated at a tertiary care tuberculosis center in India- A retrospective analysis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Secondary drug resistance tuberculosis in Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006
Multi drug resistant tuberculosis in a tertiary university hospital
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Treatment of latent tuberculosis infection among healthcare workers at a tertiary hospital in Korea
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
Mycobacterium tuberculosis
drug resistance surveillance in Belarus
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Isolation of
mycobacterium tuberculosis
and
mycobacterium africanum
from HIV/AIDS patients with pulmonary tuberculosis in Ibadan, Nigeria
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Treatment outcome of multi-drug resistant tuberculosis treated as outpatient in a tertiary care center
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept